CARDIOL THERAPEUTICS INC. (the “Corporation”) -and- CHRISTOPHER WADDICK (the “Employee”) (Each a “Party” and together the “Parties”)Employment Agreement • April 1st, 2024 • Cardiol Therapeutics Inc. • Biological products, (no disgnostic substances)
Contract Type FiledApril 1st, 2024 Company IndustryWHEREAS the Employee is currently employed by the Corporation and the terms and conditions of his employment are governed by an employment agreement dated April 16, 2018, including the addendum agreement dated December 23, 2021 (the “Employment Agreement”);
CARDIOL THERAPEUTICS INC. (the “Corporation”) -and- CHRISTOPHER WADDICK (the “Employee”) (Each a “Party” and together the “Parties”)Employment Agreement • March 29th, 2023 • Cardiol Therapeutics Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMarch 29th, 2023 Company IndustryWHEREAS the Employee is currently employed by the Corporation and the terms and conditions of his employment are governed by an employment agreement dated April 16, 2018, including the addendum agreement dated December 23, 2021 (the “Employment Agreement”);